Caitong International Asset Management Co., LTD Axsome Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 214 shares of AXSM stock, worth $22,945. This represents 0.02% of its overall portfolio holdings.
Number of Shares
214Holding current value
$22,945% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
408Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$354 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$313 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$181 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$105 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.6B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...